Evidence map›Paper›PMID 42851354›Full record

ReviewFrontiers in immunology2026

Transient short-chain fatty acid exposure and the temporal question of epithelial barrier immunity.

Rebecca Lewandowski

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rebecca LewandowskiDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of microbiome-targeted interventions often use persistence of an administered organism or endpoint metabolite abundance as markers of biological consequence, but host barriers may be altered by microbial chemistry after the initiating exposure has disappeared. Short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, provide a tractable model for this temporal problem because they connect microbial fermentation to epithelial metabolism, G protein-coupled receptor signaling, tight-junction regulation, immune tone, and chromatin-associated gene regulation. This Perspective argues that SCFA biology should be used to distinguish three outcomes at the host-microbial interface: exposure-dependent modulation, reversible epithelial reprogramming, and durable barrier imprint. Current evidence supports robust epithelial responses to SCFAs and makes persistence biologically plausible through chromatin-associated regulation and epithelial immune memory, but it does not yet establish whether brief adult SCFA exposure can alter later barrier behavior after withdrawal. Clarifying this conversion step will provide a common temporal framework for dietary, prebiotic, probiotic, postbiotic, and microbiota-transfer studies by distinguishing intervention delivery and engraftment from epithelial persistence.

Indexed as

Fatty Acids, VolatileGastrointestinal MicrobiomeImmunity, MucosalIntestinal MucosaAnimalsHumansIntestinal Barrier FunctionFatty Acids, Volatilechromatinepithelial barrierepithelial memorymicrobiomemucosal immunitypostbioticsprobioticsshort-chain fatty acids

Identifiers

PMID42851354
PMCPMC13645751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.